全球疫苗玻璃瓶市場-2022-2029

Global Glass Vaccine Vial Market - 2022-2029

出版日期: 2022年10月18日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

新疾病增加

疫苗玻璃瓶用於儲存和運輸旨在預防疾病爆發的疫苗。在過去的幾十年裡，隨著新的疾病被引入社會，流行病的興起。例如，世衛組織於 2021 年 5 月宣布埃博拉病毒爆發。 2021 年 2 月 7 日，剛果民主共和國 (DRC) 衛生部 (MOH) 宣布北基伍省維也納衛生區出現埃博拉病毒病 (EVD) 確診病例。為了對抗這些疾病，需要對高危人群進行大規模疫苗接種，從而在預測期內推動對疫苗玻璃瓶的需求激增。同時，對於 2021-22 年流感季節，CDC 估計美國有 1,700 例流感死亡、290 萬例流感病例和 28,000 例住院治療。這些疾病的高患病率和高複發率推動了對疫苗玻璃瓶的需求，以協助疫苗的儲存和運輸，促進了市場的增長。

另一方面，監管機構正在管理無菌灌裝/完成操作的污染風險，以確保它們對使用玻璃包裝的患者盡可能安全。結果，玻璃小瓶的生產及其灌裝程序變得嚴格遵守政府的安全協議，阻礙了市場的增長。

全球疫苗玻璃瓶市場報告將提供對大約 51 個市場數據表、43 個數字和 190 頁的訪問權限

A glass vaccine vial is a small glass vessel or bottle used to store medication as liquids, especially vaccines. For sterilization, glass provides greater thermal stability, increased clarity, exceptional impermeability, excellent barrier properties, chemical tolerance, enhanced regulatory approval, and lower environmental effects. A glass vaccine vial may be made either by injecting molten glass into a mold or by sectioning and finishing the tubular glass. The major factors propelling the growth of the glass vaccine vial market are growing incidences of infectious diseases spreading across the globe, such as HIV, Ebola, Hepatitis, and more. The need to protect the population from these spreading viruses creates a higher demand for vaccination served in these vials. Further, the increasing vaccine trials and development worldwide for tackling the spread of diseases drives the demand for glass vaccine vials as vaccine trials start from a limited patient base to trial on mass population. This mass trial requires a higher number of vials for vaccine transport. Moreover, the glass material used for vials is advantageous over other materials due to thermal stability, transparency, sterilization, and more, which positively impacts the inclination towards glass vaccine vials

Market Dynamics: Increasing prevalence of new disease outbreaks

Glass vaccine vial is used to store and transport vaccines made for combating the outbreaks of diseases. The previous decades have witnessed an increase in epidemics with new diseases being introduced into society. For instance: WHO declared Ebola outbreak in May 2021. On February 7, 2021 the Ministry of Health (MOH) in the Democratic Republic of the Congo (DRC) announced that a case of Ebola virus disease (EVD) had been confirmed in Biena Health Zone, North Kivu Province. To combat these diseases, large-scale vaccination of the risk-associated population is required, which surges the demand for glass vaccine vials during the forecast period. Simultaneously, for the 2021-22 flu season so far, the CDC estimated there have been 1,700 flu deaths, 2.9 million flu cases, and 28,000 hospitalizations because of the flu in the United States. The high prevalence and reoccurrence of these diseases stir the demand for glass vaccine vails to aid in the storage and transport of vaccines, driving the market growth.

On the other hand, the regulatory bodies control the contamination risk of aseptic fill/finish operations to ensure that glass packaging is as safe as possible for the patients using it. This makes the production of glass vials and their filling procedures rigid towards government safety protocols which hinder the market growth.

Market Segmentation: Molded Glass Vial segment is projected to be the dominant segment in the market during the forecast period.

Molded glass vial dominated the global market in 2021, as the molded glass vials offer higher design flexibility which provides the vial high mechanical resistance reducing the risk of breakage. Therefore, molded glass vial's increasing usage in the glass vaccine vial product types is expected to propel segmental growth shortly.

Based on application, preventive vaccines held the dominant position in the global market during the forecast period. The sudden outbreak of diseases with concentrated risk zones propels the population to take precautions against being infected by the disease, supporting the segment growth during the forecast period. Moreover, the preventive vaccine is also expected to project a considerable CAGR during the forecast period.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period

Asia-Pacific was held a dominant position in the global glass vaccine vial market in 2021. In Asia-Pacific, China is expected to represent considerable growth during the forecast period. As in the Region, the presence of major market players propels the market growth. Moreover, North America is expected to represent significant growth in terms of value during the forecast period. Well established healthcare infrastructure, along with the rise in vaccine developments, is expected to propel the market growth across the region. Glass vaccine vial market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the growth of the population and increasing patient pool, especially in India and China.

Competitive Landscape:

The glass vaccine vial market is highly competitive, owing to the presence of big food brands. The key glass vaccine vial players contributing to the growth of the global market include Schott AG, Origin Ltd, DWK Life Sciences, Nippon Electric Glass, Pacific Vial Manufacturing, Corning, SGD Pharma, Nipro, Richland Glass, Stevanato Group, Four Stars Glass, among others. The major players are adopting new product type launch and expansion strategies for global growth in the glass vaccine vial market. In November 2021, Corning opened a new pharmaceutical vial manufacturing factory in Durham, North Carolina, where it said it can produce 500 million glass vials per year to improve the domestic supply chain and deliver Covid-19 vaccines and other drugs to the U.S. and abroad.

COVID-19 Impact: Positive impact on the global glass vaccine vial market

The outbreak of COVID-19 has positively impacted the growth of the Glass Vaccine Vial market globally. The escalated cases of COVID-19 across the globe, along with the high number of vaccine trials and development coupled with COVID-19 vaccination drives, have triggered tremendous demand for glass vaccine vials. Therefore, the COVID-19 pandemic boosted the market value of the glass vaccine vial market in 2021.

The global glass vaccine vial market report would provide an access to approximately 51 market data tables, 43 figures and 190 pages

Scope and Methodology

1.1. Research Methodology
1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary

3.1. Market Snippet by Product Type
3.2. Market Snippet by Application
3.3. Market Snippet by Region

4. Market Dynamics

4.1. Market impacting factors
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
4.2. Impact analysis

5. Industry Analysis

5.1. Porter's five forces analysis
5.2. Supply Chain analysis
5.3. PEST Analysis
5.4. Pricing Analysis
5.5. Reimbursement Analysis
5.6. Regulatory Analysis
5.7. Unmet Needs
5.8. Patent Trends

6. COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives

7. By Product Type

7.1. Introduction
- 7.1.1. Market size analysis, and y-o-y growth analysis (%), By Product Type Segment
- 7.1.2. Market attractiveness index, By Product Type Segment
7.2. Molded Glass Vial*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Tubular Glass Vial

8. By Application

8.1. Introduction
- 8.1.1. Market size analysis, and y-o-y growth analysis (%), By Application Segment
- 8.1.2. Market attractiveness index, By Application Segment
8.2. Preventive Vaccine *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Therapeutic Vaccine

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key region-specific dynamics
- 9.2.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.2.5.1. U.S.
  - 9.2.5.2. Canada
  - 9.2.5.3. Mexico
9.3. South America
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.3.5.1. Brazil
  - 9.3.5.2. Argentina
  - 9.3.5.3. Rest of South America
9.4. Europe
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.4.5.1. Germany
  - 9.4.5.2. U.K.
  - 9.4.5.3. France
  - 9.4.5.4. Spain
  - 9.4.5.5. Italy
  - 9.4.5.6. Rest of Europe
9.5. Asia Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
  - 9.5.5.1. China
  - 9.5.5.2. India
  - 9.5.5.3. Japan
  - 9.5.5.4. Australia
  - 9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive scenario
10.2. Competitor strategy analysis
10.3. Market positioning/share analysis
10.4. Mergers and acquisitions analysis

11. Company Profiles

11.1. Schott AG*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Key Highlights
- 11.1.4. Financial Overview
11.2. Origin Ltd
11.3. DWK Life Sciences.
11.4. Nippon Electric Glass.
11.5. Pacific Vial Manufacturing.
11.6. SGD Pharma.
11.7. CORNING
11.8. NIPRO
11.9. RICHLAND GLASS
11.10. Stevanato Group
11.11. FOUR STARS GLASS
List not Exhaustive*